Last reviewed · How we verify
Dose escalation of SA030
Dose escalation of SA030 is a Small molecule drug developed by Suzhou Siran Biotechnology Co.,Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | Dose escalation of SA030 |
|---|---|
| Sponsor | Suzhou Siran Biotechnology Co.,Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dose escalation of SA030 CI brief — competitive landscape report
- Dose escalation of SA030 updates RSS · CI watch RSS
- Suzhou Siran Biotechnology Co.,Ltd. portfolio CI
Frequently asked questions about Dose escalation of SA030
What is Dose escalation of SA030?
Dose escalation of SA030 is a Small molecule drug developed by Suzhou Siran Biotechnology Co.,Ltd..
Who makes Dose escalation of SA030?
Dose escalation of SA030 is developed by Suzhou Siran Biotechnology Co.,Ltd. (see full Suzhou Siran Biotechnology Co.,Ltd. pipeline at /company/suzhou-siran-biotechnology-co-ltd).
What development phase is Dose escalation of SA030 in?
Dose escalation of SA030 is in Phase 1.